Physician profile

Kara M Sullivan

Gastroenterology (Internal Medicine) · Mankato, MN

NPI 1922142975

$2,420.20

in general payments reported to CMS, 2019-2025

34 companies · $243 in 2025

The $243 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

See the full distribution for Gastroenterology (Internal Medicine)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,670.55
Education$23.36

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Celgene Corporation $654.02 2021-2024 Zeposia
Abbvie INC. $141.73 2020-2024 Rinvoq
Ironwood Pharmaceuticals, INC $136.20 2019-2024
Janssen Biotech, INC. $126.43 2019-2025 Tremfya
Lilly USA, LLC $113.31 2023-2025 Omvoh
Merck Sharp & Dohme LLC $98.19 2019-2024 Dificid
Qol Medical, LLC $84.86 2019-2024 Sucraid, Sucraid
Ucb, INC. $79.05 2019-2020
Organon LLC $76.80 2021-2023 Hadlima
Daiichi Sankyo INC. $69.67 2022-2024 Injectafer
Romark Laboratories, Lc $66.72 2019-2020
Regeneron Healthcare Solutions, INC. $66.42 2022-2024 Dupixent
Sandoz INC. $60.66 2023-2024 Hyrimoz
Takeda Pharmaceuticals U.S.A., INC. $57.78 2020-2025 Entyvio
Celltrion USA INC. $57.45 2024-2025 Vegzelma, Zymfentra
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Genzyme Corporation $50.08 2019-2025
Ipsen Biopharmaceuticals, INC $47.58 2024-2025 Bylvay, Iqirvo
Gilead Sciences, INC. $43.63 2019-2021
Pfizer INC. $38.94 2021-2025
Pharmacosmos Therapeutics INC. $35.80 2025 Monoferric
Aimmune Therapeutics, INC. $33.74 2024-2025 Zenpep
Ardelyx, INC. $29.63 2022-2023 Ibsrela
Nestle Healthcare Nutrition INC. $28.68 2022-2023
Fresenius Kabi USA, LLC $27.98 2023-2024 Idacio
Intercept Pharmaceuticals, INC. $27.93 2024
Amgen INC. $25.24 2023 Amjevita, Avsola
Digestive Care, INC. $24.85 2024 Pertzye
Otsuka America Pharmaceutical, INC. $19.13 2024 Nuedexta
Ferring Pharmaceuticals INC. $18.58 2023 Rebyota
Mirum Pharmaceuticals, INC. $17.59 2025 Livmarli
Alfasigma USA, INC. $17.39 2020
Neurelis, INC. $15.82 2024 Valtoco
Capsovision, INC. $14.51 2024 Capsocam Plus
Corium, LLC $13.81 2024 Azstarys

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kara M Sullivan

$2,420.20

in general payments reported 2019-2025

Years
2019-2025
Top company
Celgene Corporation
Context
The $243 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).

https://glasscript.com/doctor/223378/kara-m-sullivan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.